The absence of anti-Covid vaccine AstraZeneca from a delivery plan shared last week by the army has raised questions about the fate of the vaccine. The British manufacturer accounts for a seventh of the country’s vaccine dose orders.
On Sunday, the paper NZZ am Sonntag wrote that the federal government is considering selling or giving away the Swiss quota if market approval continues to be delayed or is eventually denied. The review is dragging on since October because the competent authority, Swissmedic, has requested additional clinical data from a study in the US.
Nora Kronig, who is in charge of vaccine procurement, told the NZZ am Sonntag that the data situation is currently uncertain, which is why AstraZeneca is not listed in the delivery plan. She added that withdrawal from the sales contract is not an option at the moment but said the order would be reexamined if the vaccine fails to get approval.
According to Kronig, Switzerland is not dependent on AstraZeneca doses and the government does not rule out passing on the doses to others if necessary. A spokesperson for AstraZeneca told the paper that the company is ready to swiftly deliver doses to Switzerland as soon as Swissmedic approves the vaccine.
Swiss justice minister hopes EU reform will reduce irregular migration
This content was published on
The European Union’s (EU) New Pact on Migration and Asylum aims to curb irregular migration within Schengen, Justice Minister Beat Jans said on Tuesday.
Swiss electricity supply outlook positive despite uncertainties
This content was published on
Thanks to well-filled gas stores in Europe and increased availability of French nuclear power, the Swiss Federal Electricity Commission is optimistic.
Finance minister wants Swiss banks to hold more equity
This content was published on
Finance Minister Karin Keller-Sutter has repeated calls for banks and their holdings in subsidiaries abroad to hold more equity.
Telecoms sector kept Swiss competitions regulator busy in 2023
This content was published on
Last year, the Swiss Competition Commission (COMCO) conducted 27 investigations and initiated 17 preliminary investigations.
This content was published on
Although Swiss International Air Lines (SWISS) achieved higher revenue at the start of the year, it suffered a dip in profits.
40,000 signatures against animal testing in Switzerland
This content was published on
Switzerland should do away with “restrictive” animal testing and should become a model for innovative, effective, and pain-free scientific research.
More than 45,000 signatures in favour of federal funding for UNRWA
This content was published on
The Foreign Affairs Committee of the House of Representatives (FAC) is expected to decide on the funding of the UNRWA at the beginning of the week.
This content was published on
At the end of January 2024, 6,881 men and women were behind bars in Switzerland. Almost 95% of all places were occupied, the highest number since 2014.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss sign next vaccine agreement with AstraZeneca
This content was published on
Switzerland signs agreement with British pharma company AstraZeneca to pre-order up to 5.3 million doses of a Covid-19 vaccine under development.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.